Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EyePoint Pharmaceuticals, Inc. Director's Dealing 2008

Jun 27, 2008

32254_dirs_2008-06-27_71ebbea2-cf8e-4639-b5ed-fd9cca286f22.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2008-06-19

Reporting Person: Soja Michael (VP Finance, CFO & Treasurer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 69011 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to purchase CHESS Depositary Interests ("CDI's") $12.3487 2011-09-30 CDIs (6250) Direct
Option to purchase CDIs $34.9563 2010-09-30 CDIs (5937) Direct
Option to purchase CDIs $5.2245 2012-09-30 CDIs (18750) Direct

Footnotes

F1: 2,083 options vested on October 18, 2007, another 2,083 options vest on October 18, 2008, and the final 2,084 options vest on October 18,2009.

F2: 2,968 options vested on December 30, 2006. The other 2,969 options were scheduled to vest on December 30, 2007, but did not vest on that date because the options' vesting was and remains subject to performance conditions that have not yet been defined. The date, if any, that the other 2,969 options may become exercisable is therefore currently unknown.

F3: 6,250 options vest on October 18, 2008, another 6,250 options vest on October 18, 2009, and the final 6,250 options vest on October 18, 2010.

F4: Each CDI represents an interest in one underlying share of common stock of pSivida Corp.

F5: Per CDI. The exercise price was converted from A$0.325 using the noon-day rate of exchange of the Federal Reserve Bank of New York on June 19, 2008, which was US$0.9499 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.

F6: Per CDI. The exercise price was converted from A$0.92 using the noon-day rate of exchange of the Federal Reserve Bank of New York on June 19, 2008, which was US$0.9499 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.

F7: Per CDI. The exercise price was converted from A$0.1375 using the noon-day rate of exchange of the Federal Reserve Bank of New York on June 19, 2008, which was US$0.9499 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.